OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Chemotherapy and cognition: comprehensive review on doxorubicin-induced chemobrain
Sara Emad El-Agamy, Amal Kamal Abdel‐Aziz, Ahmed Esmat, et al.
Cancer Chemotherapy and Pharmacology (2019) Vol. 84, Iss. 1, pp. 1-14
Closed Access | Times Cited: 77
Sara Emad El-Agamy, Amal Kamal Abdel‐Aziz, Ahmed Esmat, et al.
Cancer Chemotherapy and Pharmacology (2019) Vol. 84, Iss. 1, pp. 1-14
Closed Access | Times Cited: 77
Showing 1-25 of 77 citing articles:
Long‐COVID syndrome‐associated brain fog and chemofog: Luteolin to the rescue
Theoharis C. Theoharides, Christos Cholevas, Konstantinos S. Polyzoidis, et al.
BioFactors (2021) Vol. 47, Iss. 2, pp. 232-241
Open Access | Times Cited: 187
Theoharis C. Theoharides, Christos Cholevas, Konstantinos S. Polyzoidis, et al.
BioFactors (2021) Vol. 47, Iss. 2, pp. 232-241
Open Access | Times Cited: 187
Chemotherapy-induced cognitive impairment (CICI): An overview of etiology and pathogenesis
Noha M. Mounier, Amany E. Abdel-Maged, Sara A. Wahdan, et al.
Life Sciences (2020) Vol. 258, pp. 118071-118071
Closed Access | Times Cited: 101
Noha M. Mounier, Amany E. Abdel-Maged, Sara A. Wahdan, et al.
Life Sciences (2020) Vol. 258, pp. 118071-118071
Closed Access | Times Cited: 101
Doxorubicin-Induced Cognitive Impairment: The Mechanistic Insights
Jiajia Du, Aoxue Zhang, Jing Li, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 76
Jiajia Du, Aoxue Zhang, Jing Li, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 76
Berberine ameliorates doxorubicin-induced cognitive impairment (chemobrain) in rats
Fatma H. Shaker, Marwa O. El-Derany, Sara A. Wahdan, et al.
Life Sciences (2021) Vol. 269, pp. 119078-119078
Closed Access | Times Cited: 71
Fatma H. Shaker, Marwa O. El-Derany, Sara A. Wahdan, et al.
Life Sciences (2021) Vol. 269, pp. 119078-119078
Closed Access | Times Cited: 71
Potential roles and prognostic significance of exosomes in cancer drug resistance
Mostafa Mostafazadeh, Nasser Samadi, Houman Kahroba, et al.
Cell & Bioscience (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 70
Mostafa Mostafazadeh, Nasser Samadi, Houman Kahroba, et al.
Cell & Bioscience (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 70
A Review on the Neurotoxic Effects of Doxorubicin
Katarzyna Kamińska, Agnieszka Cudnoch‐Jędrzejewska
Neurotoxicity Research (2023) Vol. 41, Iss. 5, pp. 383-397
Open Access | Times Cited: 26
Katarzyna Kamińska, Agnieszka Cudnoch‐Jędrzejewska
Neurotoxicity Research (2023) Vol. 41, Iss. 5, pp. 383-397
Open Access | Times Cited: 26
Complications and comorbidities associated with antineoplastic chemotherapy: Rethinking drug design and delivery for anticancer therapy
Xiaoman Mao, Shuang Wu, Dandan Huang, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 7, pp. 2901-2926
Open Access | Times Cited: 8
Xiaoman Mao, Shuang Wu, Dandan Huang, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 7, pp. 2901-2926
Open Access | Times Cited: 8
Doxorubicin chemotherapy-induced “chemo-brain”: Meta-analysis
Sarah Eide, Zhong‐Ping Feng
European Journal of Pharmacology (2020) Vol. 881, pp. 173078-173078
Closed Access | Times Cited: 66
Sarah Eide, Zhong‐Ping Feng
European Journal of Pharmacology (2020) Vol. 881, pp. 173078-173078
Closed Access | Times Cited: 66
A Short‐Lived but Highly Cytotoxic Vanadium(V) Complex as a Potential Drug Lead for Brain Cancer Treatment by Intratumoral Injections
Aviva Levina, Adriana Pires Vieira, Asanka Wijetunga, et al.
Angewandte Chemie International Edition (2020) Vol. 59, Iss. 37, pp. 15834-15838
Closed Access | Times Cited: 65
Aviva Levina, Adriana Pires Vieira, Asanka Wijetunga, et al.
Angewandte Chemie International Edition (2020) Vol. 59, Iss. 37, pp. 15834-15838
Closed Access | Times Cited: 65
Chemotherapy-Induced Cognitive Impairment and Hippocampal Neurogenesis: A Review of Physiological Mechanisms and Interventions
Melanie J. Sekeres, Meenakshie Bradley-Garcia, Alonso Martínez-Canabal, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 12697-12697
Open Access | Times Cited: 50
Melanie J. Sekeres, Meenakshie Bradley-Garcia, Alonso Martínez-Canabal, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 12697-12697
Open Access | Times Cited: 50
“Focused Ultrasound-mediated Drug Delivery in Humans – a Path Towards Translation in Neurodegenerative Diseases”
Joanna M. Wasielewska, Anthony R. White
Pharmaceutical Research (2022) Vol. 39, Iss. 3, pp. 427-439
Open Access | Times Cited: 33
Joanna M. Wasielewska, Anthony R. White
Pharmaceutical Research (2022) Vol. 39, Iss. 3, pp. 427-439
Open Access | Times Cited: 33
Chemobrain: A review on mechanistic insight, targets and treatments
Vanishree Rao, Rashmi Bhushan, Priyanka Kumari, et al.
Advances in cancer research (2022), pp. 29-76
Closed Access | Times Cited: 30
Vanishree Rao, Rashmi Bhushan, Priyanka Kumari, et al.
Advances in cancer research (2022), pp. 29-76
Closed Access | Times Cited: 30
Role of flavonoids against adriamycin toxicity
María D. Navarro‐Hortal, Alfonso Varela‐López, José M. Romero‐Márquez, et al.
Food and Chemical Toxicology (2020) Vol. 146, pp. 111820-111820
Closed Access | Times Cited: 44
María D. Navarro‐Hortal, Alfonso Varela‐López, José M. Romero‐Márquez, et al.
Food and Chemical Toxicology (2020) Vol. 146, pp. 111820-111820
Closed Access | Times Cited: 44
The microbiota-gut-brain axis: An emerging therapeutic target in chemotherapy-induced cognitive impairment
Courtney B. Subramaniam, Joanne M. Bowen, Marc A. Gladman, et al.
Neuroscience & Biobehavioral Reviews (2020) Vol. 116, pp. 470-479
Open Access | Times Cited: 40
Courtney B. Subramaniam, Joanne M. Bowen, Marc A. Gladman, et al.
Neuroscience & Biobehavioral Reviews (2020) Vol. 116, pp. 470-479
Open Access | Times Cited: 40
Animal models of chemotherapy-induced cognitive decline in preclinical drug development
Jeena John, Manas Kinra, Jayesh Mudgal, et al.
Psychopharmacology (2021) Vol. 238, Iss. 11, pp. 3025-3053
Open Access | Times Cited: 37
Jeena John, Manas Kinra, Jayesh Mudgal, et al.
Psychopharmacology (2021) Vol. 238, Iss. 11, pp. 3025-3053
Open Access | Times Cited: 37
Advantageous Reactivity of Unstable Metal Complexes: Potential Applications of Metal-Based Anticancer Drugs for Intratumoral Injections
Aviva Levina, Debbie C. Crans, Peter A. Lay
Pharmaceutics (2022) Vol. 14, Iss. 4, pp. 790-790
Open Access | Times Cited: 27
Aviva Levina, Debbie C. Crans, Peter A. Lay
Pharmaceutics (2022) Vol. 14, Iss. 4, pp. 790-790
Open Access | Times Cited: 27
Galangin mitigates DOX-induced cognitive impairment in rats: Implication of NOX-1/Nrf-2/HMGB1/TLR4 and TNF-α/MAPKs/RIPK/MLKL/BDNF
Sarah A. Abd El‐Aal, Mohamed Abdelrahman, Ahmed Reda, et al.
NeuroToxicology (2022) Vol. 92, pp. 77-90
Closed Access | Times Cited: 25
Sarah A. Abd El‐Aal, Mohamed Abdelrahman, Ahmed Reda, et al.
NeuroToxicology (2022) Vol. 92, pp. 77-90
Closed Access | Times Cited: 25
Chemobrain in Breast Cancer: Mechanisms, Clinical Manifestations, and Potential Interventions
Giovana R. Onzi, Nathalia D’Agustini, Solange Cristina García, et al.
Drug Safety (2022) Vol. 45, Iss. 6, pp. 601-621
Closed Access | Times Cited: 23
Giovana R. Onzi, Nathalia D’Agustini, Solange Cristina García, et al.
Drug Safety (2022) Vol. 45, Iss. 6, pp. 601-621
Closed Access | Times Cited: 23
DNA Damage and Repair in Migraine: Oxidative Stress and Beyond
Michał Fila, Aleksandra Jabłkowska, Elżbieta Pawłowska, et al.
The Neuroscientist (2022) Vol. 29, Iss. 3, pp. 277-286
Closed Access | Times Cited: 22
Michał Fila, Aleksandra Jabłkowska, Elżbieta Pawłowska, et al.
The Neuroscientist (2022) Vol. 29, Iss. 3, pp. 277-286
Closed Access | Times Cited: 22
A real-world analysis of FDA Adverse Event Reporting System (FAERS) events for liposomal and conventional doxorubicins
Huiling Su, Jing Jia, Yuxiang Mao, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Huiling Su, Jing Jia, Yuxiang Mao, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
The chemotherapy agent doxorubicin induces CNS expression of Ascl1, a regulator of adult neurogenesis and differentiation
Christi Anne S. Ng, Morgan Pedus, Madeline F. Lee, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Christi Anne S. Ng, Morgan Pedus, Madeline F. Lee, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Hippocampal neural stem cells facilitate access from circulation via apical cytoplasmic processes
Tamar Licht, Esther Sasson, Batia Bell, et al.
eLife (2020) Vol. 9
Open Access | Times Cited: 35
Tamar Licht, Esther Sasson, Batia Bell, et al.
eLife (2020) Vol. 9
Open Access | Times Cited: 35
Roflumilast Attenuates Doxorubicin-Induced Cardiotoxicity by Targeting Inflammation and Cellular Senescence in Cardiomyocytes Mediated by SIRT1
Sheng Zhang, Peng Wu, Jia Liu, et al.
Drug Design Development and Therapy (2021) Vol. Volume 15, pp. 87-97
Open Access | Times Cited: 27
Sheng Zhang, Peng Wu, Jia Liu, et al.
Drug Design Development and Therapy (2021) Vol. Volume 15, pp. 87-97
Open Access | Times Cited: 27
Potential of Natural Phenolic Compounds against Doxorubicin-Induced Chemobrain: Biological and Molecular Mechanisms Involved
Simona Serini, Gabriella Calviello
Antioxidants (2024) Vol. 13, Iss. 4, pp. 486-486
Open Access | Times Cited: 4
Simona Serini, Gabriella Calviello
Antioxidants (2024) Vol. 13, Iss. 4, pp. 486-486
Open Access | Times Cited: 4
α-Bisabolol alleviates doxorubicin-induced cognitive dysfunction in rats via enhancing the hippocampal BDNF/TrKB signaling and inhibiting neuroinflammation
Sara T. Elazab, Walter H. Hsu
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Sara T. Elazab, Walter H. Hsu
Frontiers in Pharmacology (2025) Vol. 16
Open Access
